Systemic Therapy Advances for HER2-Positive and Triple Negative Breast Cancer: What the Surgeon Needs to Know. Downs-Canner S, Weiss A. Clin Breast Cancer 2024 Mar 13:S1526-8209(24)00077.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Downs-Canner S, Weiss A. Systemic Therapy Advances for HER2-Positive and Triple Negative Breast Cancer: What the Surgeon Needs to Know. Clin Breast Cancer 2024 Mar 13:S1526-8209(24)00077.
PMID: 38616443